Related Experiment Video
Updated: Aug 16, 2026

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
Published on: August 11, 2015
Cognitive therapy does not prevent a response to tryptophan depletion in patients also treated with antidepressants
A J Willem Van der Does1, Linda Booij
1Department of Psychology, Leiden University, The Netherlands. vanderdoes@fsw.leiden.univ.nl
Background:
Acute tryptophan depletion (ATD) induces depressive symptoms in remitted depressed patients treated with serotonergic medications, but not in patients treated with noradrenergic medications or electroconvulsive therapy. A recent study suggests that cognitive therapy (CT) protects against the effects of ATD, but the evidence is questionable. The present study compared the effect of ATD in patients who were treated with antidepressant medication and CT (n = 17) versus antidepressant medication alone (n = 23) during their latest episode.
Methods:
Forty remitted depressed patients underwent high-dose and low-dose ATD in a randomized double-blind crossover design.
Results:
There were no differences in response to ATD between treatment groups. This applied to groups defined by lifetime and by recent CT experience.
Conclusions:
Cognitive therapy does not protect against the effects of rapidly lowered plasma tryptophan levels in remitted depressed patients who are also treated with antidepressant medication.
Related Concept Videos
Antidepressant Drugs: MAOIs and Other Agents
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
Cognitive Therapy
Antidepressant Drugs: Overview
Electroconvulsive Therapy
Drug Therapy
Antianxiety Medications
